A Novel Tongue Squamous Cell Carcinoma Cell Line Escapes from Immune Recognition due to Genetic Alterations in HLA Class I Complex

Immune checkpoint inhibitors (ICI) have made progress in the field of anticancer treatment, but a certain number of PD-L1 negative OSCC patients still have limited benefits from ICI immuno-therapy because of primary immune evasion due to immunodeficiency. However, in existing human OSCC cell lines,...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Xiaofeng, Sun, Yanan, Li, Yiwei, Ma, Jiyuan, Lv, Yinan, Hu, Yaying, Zhou, Yi, Zhang, Jiali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818362/
https://www.ncbi.nlm.nih.gov/pubmed/36611830
http://dx.doi.org/10.3390/cells12010035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818362/
https://www.ncbi.nlm.nih.gov/pubmed/36611830
http://dx.doi.org/10.3390/cells12010035

Ejemplares similares